GVOKE VIALDX
Live / Registered — Registered (as of 25 Aug 2026)
What this means for you
Registered since 25 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Aug 2032: the §8 declaration of use).
Record
- Serial number
- 98978730
- Registration number
- 8414990
- Mark type
- Word mark
- Filed
- 01 Sept 2023
- Published for opposition
- 11 Jun 2024
- Registered
- 25 Aug 2026
- Next maintenance filing
- §8 declaration of use, due by 25 Aug 2032 (grace period to 25 Feb 2033)
- Attorney of record
- Tracy-Gene G. Durkin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for in vivo diagnostic use; pharmaceutical preparations for diagnostic radiology use
Owner
- Xeris Pharmaceuticals, Inc., Chicago, IL, US
- Xeris Pharmaceuticals, Inc., Chicago, IL, US
- Xeris Pharmaceuticals, Inc., Chicago, IL, US
Prior registrations
Prosecution history
- 25 Aug 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
- 05 Aug 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Aug 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jan 2026 — USE AMENDMENT FILED
- 05 Aug 2026 — DIVISIONAL PROCESSING COMPLETE
- 14 Jan 2026 — DIVISIONAL REQUEST RECEIVED
- 05 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 May 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Jan 2026 — TEAS STATEMENT OF USE RECEIVED
- 14 Jan 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 06 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Aug 2025 — SOU EXTENSION 2 GRANTED
- 05 Aug 2025 — SOU EXTENSION 2 FILED